{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:31:25Z","timestamp":1793165485116,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Central Plains Science and Technology Innovation leading talent Program","award":["244200510016"],"award-info":[{"award-number":["244200510016"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2010001"],"award-info":[{"award-number":["2022YFC2010001"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Independent Innovation Project of Zhengzhou University","award":["ZC20240105"],"award-info":[{"award-number":["ZC20240105"]}],"id":[{"id":"https:\/\/ror.org\/04ypx8c21","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key scientific research project of Henan University","award":["25A310026"],"award-info":[{"award-number":["25A310026"]}],"id":[{"id":"https:\/\/ror.org\/003xyzq10","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medical Science and Technology Research Project of Henan Province","award":["SBGJ202402100; LHGJ20230074"],"award-info":[{"award-number":["SBGJ202402100; LHGJ20230074"]}]},{"name":"Henan Provincial Science and Technology Tackling Program Project Funding","award":["242102311121; 222102310283"],"award-info":[{"award-number":["242102311121; 222102310283"]}]},{"name":"Key Science and Technology Projects of Henan Province","award":["241100310300"],"award-info":[{"award-number":["241100310300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People\u2019s Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan\u2013Meier survival curves for MetS events, with significance tested using the log-rank method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR)\u2009=\u20091.13, 95% confidence interval (CI): 1.12\u20131.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR\u2009=\u200930.33; 95% CI: 19.00\u201348.43,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (\n                      <jats:italic>P<\/jats:italic>\n                      for nonlinearity\u2009&lt;\u20090.001), with risk escalation slowing down when the VFA exceeded 100\u00a0cm\u00b2. ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC\u2009=\u20090.844, sensitivity\u2009=\u20090.839, specificity\u2009=\u20090.793, and accuracy\u2009=\u20090.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100\u00a0cm\u00b2. VFA\u2009=\u2009162.85\u00a0cm\u00b2 may serve as an accurate and effective predictor for MetS in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-025-02482-0","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T07:10:11Z","timestamp":1739862611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association between visceral fat area and metabolic syndrome in individuals with normal body weight: insights from a Chinese health screening dataset"],"prefix":"10.1186","volume":"24","author":[{"given":"Yongbing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"2482_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","volume":"10","author":"IJ Neeland","year":"2024","unstructured":"Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, Powell-Wiley TM, Despr\u00e9s JP. Metabolic syndrome. Nat Rev Dis Primers. 2024;10:77.","journal-title":"Nat Rev Dis Primers"},{"key":"2482_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/joim.13355","volume":"290","author":"LM Pammer","year":"2021","unstructured":"Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, Lipovsek J, Meiselbach H, Busch M, Eckardt KU, Kronenberg F. Association of the metabolic syndrome with mortality and major adverse cardiac events: a large chronic kidney disease cohort. J Intern Med. 2021;290:1219\u201332.","journal-title":"J Intern Med"},{"key":"2482_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2213-8587(23)00086-4","volume":"11","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 2023;11:426\u201340.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2482_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.","journal-title":"Curr Hypertens Rep"},{"key":"2482_CR5","doi-asserted-by":"publisher","first-page":"1073824","DOI":"10.3389\/fpubh.2023.1073824","volume":"11","author":"J Gui","year":"2023","unstructured":"Gui J, Li Y, Liu H, Guo LL, Li J, Lei Y, Li X, Sun L, Yang L, Yuan T, et al. Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study. Front Public Health. 2023;11:1073824.","journal-title":"Front Public Health"},{"key":"2482_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12933-023-01765-z","volume":"22","author":"RM Sandsdal","year":"2023","unstructured":"Sandsdal RM, Juhl CR, Jensen SBK, Lundgren JR, Janus C, Blond MB, Rosenkilde M, Bogh AF, Gliemann L, Jensen JB, et al. Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial. Cardiovasc Diabetol. 2023;22:41.","journal-title":"Cardiovasc Diabetol"},{"key":"2482_CR7","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1210\/clinem\/dgad152","volume":"108","author":"J Ye","year":"2023","unstructured":"Ye J, Guo K, Li X, Yang L, Zhou Z. The prevalence of metabolically unhealthy normal weight and its influence on the risk of diabetes. J Clin Endocrinol Metab. 2023;108:2240\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"2482_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.orcp.2017.10.005","volume":"12","author":"B Wang","year":"2018","unstructured":"Wang B, Zhang M, Wang S, Wang C, Wang J, Li L, Zhang L, Ren Y, Han C, Zhao Y, et al. Dynamic status of metabolically healthy overweight\/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus: a cohort study of a rural adult Chinese population. Obes Res Clin Pract. 2018;12:61\u201371.","journal-title":"Obes Res Clin Pract"},{"key":"2482_CR9","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","volume":"30","author":"L Busetto","year":"2024","unstructured":"Busetto L, Dicker D, Fr\u00fchbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024;30:2395\u20139.","journal-title":"Nat Med"},{"key":"2482_CR10","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3390\/nu11061430","volume":"11","author":"H Nishizawa","year":"2019","unstructured":"Nishizawa H, Shimomura I. Population approaches targeting metabolic syndrome focusing on Japanese trials. Nutrients. 2019;11:1430.","journal-title":"Nutrients"},{"key":"2482_CR11","doi-asserted-by":"publisher","first-page":"17034","DOI":"10.1038\/nrdp.2017.34","volume":"3","author":"P Gonz\u00e1lez-Muniesa","year":"2017","unstructured":"Gonz\u00e1lez-Muniesa P, M\u00e1rtinez-Gonz\u00e1lez MA, Hu FB, Despr\u00e9s JP, Matsuzawa Y, Loos RJF, Moreno LA, Bray GA, Martinez JA, Obesity. Nat Rev Dis Primers. 2017;3:17034.","journal-title":"Nat Rev Dis Primers"},{"key":"2482_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11154-013-9252-x","volume":"14","author":"CM Phillips","year":"2013","unstructured":"Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord. 2013;14:219\u201327.","journal-title":"Rev Endocr Metab Disord"},{"key":"2482_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ajcn\/79.3.379","volume":"79","author":"I Janssen","year":"2004","unstructured":"Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379\u201384.","journal-title":"Am J Clin Nutr"},{"key":"2482_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cpf.12700","volume":"41","author":"GJ Brewer","year":"2021","unstructured":"Brewer GJ, Blue MNM, Hirsch KR, Saylor HE, Gould LM, Nelson AG, Smith-Ryan AE. Validation of InBody 770 bioelectrical impedance analysis compared to a four-compartment model criterion in young adults. Clin Physiol Funct Imaging. 2021;41:317\u201325.","journal-title":"Clin Physiol Funct Imaging"},{"key":"2482_CR15","doi-asserted-by":"publisher","first-page":"e048221","DOI":"10.1136\/bmjopen-2020-048221","volume":"11","author":"Z Xu","year":"2021","unstructured":"Xu Z, Liu Y, Yan C, Yang R, Xu L, Guo Z, Yu A, Cheng X, Ma L, Hu C, et al. Measurement of visceral fat and abdominal obesity by single-frequency bioelectrical impedance and CT: a cross-sectional study. BMJ Open. 2021;11:e048221.","journal-title":"BMJ Open"},{"key":"2482_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000520418","volume":"15","author":"D Nagayama","year":"2022","unstructured":"Nagayama D, Watanabe Y, Yamaguchi T, Suzuki K, Saiki A, Fujishiro K, Shirai K. Issue of Waist circumference for the diagnosis of metabolic syndrome regarding arterial stiffness: possible utility of a body shape index in Middle-aged nonobese Japanese urban residents receiving Health Screening. Obes Facts. 2022;15:160\u20139.","journal-title":"Obes Facts"},{"key":"2482_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cac2.12393","volume":"43","author":"R Feng","year":"2023","unstructured":"Feng R, Su Q, Huang X, Basnet T, Xu X, Ye W. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration? Cancer Commun (Lond). 2023;43:75\u201386.","journal-title":"Cancer Commun (Lond)"},{"key":"2482_CR18","doi-asserted-by":"publisher","first-page":"e013831","DOI":"10.1136\/bmjopen-2016-013831","volume":"7","author":"Y Tatsumi","year":"2017","unstructured":"Tatsumi Y, Nakao YM, Masuda I, Higashiyama A, Takegami M, Nishimura K, Watanabe M, Ohkubo T, Okamura T, Miyamoto Y. Risk for metabolic diseases in normal weight individuals with visceral fat accumulation: a cross-sectional study in Japan. BMJ Open. 2017;7:e013831.","journal-title":"BMJ Open"},{"key":"2482_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3904\/kjim.2018.427","volume":"36","author":"HH Jeon","year":"2021","unstructured":"Jeon HH, Lee YK, Kim DH, Pak H, Shin SY, Seo JH. Risk for metabolic syndrome in the population with visceral fat area measured by bioelectrical impedance analysis. Korean J Intern Med. 2021;36:97\u2013105.","journal-title":"Korean J Intern Med"},{"key":"2482_CR20","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.2147\/DMSO.S483497","volume":"17","author":"J Wu","year":"2024","unstructured":"Wu J, Lin X, Yin X, Xu Z, Wu N, Zhang Z, Zhou J, Li H. Comparison of incidence of metabolic syndrome and five obesity- and lipid-linked indicators for Predicting Metabolic Syndrome among normal-weight and overweight adults. Diabetes Metab Syndr Obes. 2024;17:3509\u201320.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2482_CR21","first-page":"83","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83\u201396.","journal-title":"Biomed Environ Sci"},{"key":"2482_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247\u201354.","journal-title":"Ann Intern Med"},{"key":"2482_CR23","doi-asserted-by":"publisher","first-page":"154456","DOI":"10.1016\/j.metabol.2020.154456","volume":"115","author":"Q Zeng","year":"2021","unstructured":"Zeng Q, Wang L, Dong S, Zha X, Ran L, Li Y, Chen S, Gao J, Li S, Lu Y, et al. CT-derived abdominal adiposity: distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China. Metabolism. 2021;115:154456.","journal-title":"Metabolism"},{"key":"2482_CR24","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/dme.14060","volume":"36","author":"L Huo","year":"2019","unstructured":"Huo L, Li K, Deng W, Wang L, Xu L, Shaw JE, Jia P, Zhou D, Cheng XG. Optimal cut-points of visceral adipose tissue areas for cardiometabolic risk factors in a Chinese population: a cross-sectional study. Diabet Med. 2019;36:1268\u201375.","journal-title":"Diabet Med"},{"key":"2482_CR25","doi-asserted-by":"publisher","first-page":"378632","DOI":"10.1155\/2013\/378632","volume":"2013","author":"L Wang","year":"2013","unstructured":"Wang L, Wang W, Xu L, Cheng X, Ma Y, Liu D, Guo Z, Su Y, Wang Q. Relation of visceral and subcutaneous adipose tissue to bone mineral density in Chinese women. Int J Endocrinol. 2013;2013:378632.","journal-title":"Int J Endocrinol"},{"key":"2482_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pcad.2018.07.003","volume":"61","author":"A Elagizi","year":"2018","unstructured":"Elagizi A, Kachur S, Lavie CJ, Carbone S, Pandey A, Ortega FB, Milani RV. An overview and update on obesity and the obesity Paradox in Cardiovascular diseases. Prog Cardiovasc Dis. 2018;61:142\u201350.","journal-title":"Prog Cardiovasc Dis"},{"key":"2482_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.18544\/PEDM-23.02.0079","volume":"23","author":"Z Zdrojewicz","year":"2017","unstructured":"Zdrojewicz Z, Popowicz E, Szyca M, Michalik T, \u015amieszniak B. TOFI phenotype - its effect on the occurrence of diabetes. Pediatr Endocrinol Diabetes Metab. 2017;23:96\u2013100.","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"2482_CR28","doi-asserted-by":"crossref","unstructured":"Lin R, Jia Y, Wu F, Meng Y, Sun Q, Jia L. Combined Exposure to Fructose and Bisphenol A Exacerbates Abnormal Lipid Metabolism in Liver of Developmental Male Rats. Int J Environ Res Public Health. 2019,16(21):4152.","DOI":"10.3390\/ijerph16214152"},{"key":"2482_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","volume":"116","author":"CS Fox","year":"2007","unstructured":"Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39\u201348.","journal-title":"Circulation"},{"key":"2482_CR30","doi-asserted-by":"publisher","first-page":"584541","DOI":"10.1155\/2012\/584541","volume":"2012","author":"I Dichi","year":"2012","unstructured":"Dichi I, Sim\u00e3o AN, Vannucchi H, Curi R, Calder PC. Metabolic syndrome: epidemiology, pathophysiology, and nutrition intervention. J Nutr Metab. 2012;2012:584541.","journal-title":"J Nutr Metab"},{"key":"2482_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ebiom.2018.10.025","volume":"37","author":"V Rakotoarivelo","year":"2018","unstructured":"Rakotoarivelo V, Lacraz G, Mayhue M, et al. Inflammatory cytokine profiles in visceral and subcutaneous adipose tissues of obese patients undergoing bariatric surgery reveal lack of correlation with obesity or diabetes. EBioMedicine. 2018;37:564\u20138.","journal-title":"EBioMedicine"},{"issue":"27","key":"2482_CR32","doi-asserted-by":"publisher","first-page":"24944","DOI":"10.1074\/jbc.M300423200","volume":"278","author":"Z Gao","year":"2003","unstructured":"Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem. 2003;278(27):24944\u201350.","journal-title":"J Biol Chem"},{"issue":"16","key":"2482_CR33","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.1074\/jbc.M210689200","volume":"278","author":"JJ Senn","year":"2003","unstructured":"Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem. 2003;278(16):13740\u20136.","journal-title":"J Biol Chem"},{"key":"2482_CR34","doi-asserted-by":"publisher","first-page":"R1286","DOI":"10.1152\/ajpregu.00653.2001","volume":"282","author":"T Tchkonia","year":"2002","unstructured":"Tchkonia T, Giorgadze N, Pirtskhalava T, Tchoukalova Y, Karagiannides I, Forse RA, DePonte M, Stevenson M, Guo W, Han J, et al. Fat Depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol. 2002;282:R1286\u20131296.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2482_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tem.2008.10.006","volume":"20","author":"B Muhlhausler","year":"2009","unstructured":"Muhlhausler B, Smith SR. Early-life origins of metabolic dysfunction: role of the adipocyte. Trends Endocrinol Metab. 2009;20:51\u20137.","journal-title":"Trends Endocrinol Metab"},{"issue":"Suppl 1","key":"2482_CR36","doi-asserted-by":"publisher","first-page":"S307","DOI":"10.1016\/j.dsx.2017.03.006","volume":"11","author":"H Zand","year":"2017","unstructured":"Zand H, Morshedzadeh N, Naghashian F. Signaling pathways linking inflammation to insulin resistance. Diabetes Metab Syndr. 2017;11(Suppl 1):S307\u20139.","journal-title":"Diabetes Metab Syndr"},{"key":"2482_CR37","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1291\/hypres.31.1283","volume":"31","author":"E Oda","year":"2008","unstructured":"Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res. 2008;31:1283\u201391.","journal-title":"Hypertens Res"},{"key":"2482_CR38","doi-asserted-by":"crossref","unstructured":"Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. J Obes. 2013, 2013:393192.","DOI":"10.1155\/2013\/393192"},{"issue":"Suppl 1","key":"2482_CR39","first-page":"s16","volume":"14","author":"RN Bergman","year":"2006","unstructured":"Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, Kabir M, Hucking K, Ader M. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obes (Silver Spring). 2006;14(Suppl 1):s16\u20139.","journal-title":"Obes (Silver Spring)"},{"key":"2482_CR40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5:1218\u201340.","journal-title":"Nutrients"},{"key":"2482_CR41","first-page":"S2213","volume":"13","author":"N Stefan","year":"2024","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2024;13:S2213. 8587(24)00318-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2482_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","volume":"7","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schick F, Birkenfeld AL, H\u00e4ring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023;7(2):236\u201352.","journal-title":"Cell Metab"},{"key":"2482_CR43","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/nu5030928","volume":"5","author":"D Nikolic","year":"2013","unstructured":"Nikolic D, Katsiki N, Montalto G, Isenovic ER, Mikhailidis DP, Rizzo M. Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients. 2013;5:928\u201348.","journal-title":"Nutrients"},{"key":"2482_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4082\/kjfm.18.0122","volume":"41","author":"YH Lee","year":"2020","unstructured":"Lee YH, Park J, Min S, Kang O, Kwon H, Oh SW. Impact of visceral obesity on the risk of Incident Metabolic Syndrome in metabolically healthy normal weight and overweight groups: a longitudinal cohort study in Korea. Korean J Fam Med. 2020;41:229\u201336.","journal-title":"Korean J Fam Med"},{"key":"2482_CR45","doi-asserted-by":"publisher","first-page":"e2103719","DOI":"10.1002\/advs.202103719","volume":"9","author":"H Duan","year":"2022","unstructured":"Duan H, Jing L, Xiang J, Ju C, Wu Z, Liu J, Ma X, Chen X, Liu Z, Feng J, Yan X. CD146 associates with Gp130 to Control a macrophage pro-inflammatory program that regulates the metabolic response to obesity. Adv Sci (Weinh). 2022;9:e2103719.","journal-title":"Adv Sci (Weinh)"},{"key":"2482_CR46","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3346\/jkms.2011.26.7.906","volume":"26","author":"HI Kim","year":"2011","unstructured":"Kim HI, Kim JT, Yu SH, Kwak SH, Jang HC, Park KS, Kim SY, Lee HK, Cho YM. Gender differences in diagnostic values of visceral fat area and waist circumference for predicting metabolic syndrome in koreans. J Korean Med Sci. 2011;26:906\u201313.","journal-title":"J Korean Med Sci"},{"key":"2482_CR47","doi-asserted-by":"publisher","first-page":"e13767","DOI":"10.1111\/obr.13767","volume":"25","author":"JP Bennett","year":"2024","unstructured":"Bennett JP, Prado CM, Heymsfield SB, Shepherd JA. Evaluation of visceral adipose tissue thresholds for elevated metabolic syndrome risk across diverse populations: a systematic review. Obes Rev. 2024;25:e13767.","journal-title":"Obes Rev"},{"key":"2482_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/07853890.2010.526138","volume":"44","author":"A Hiuge-Shimizu","year":"2012","unstructured":"Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, Suzuki S, Takaya N, Nakagawa T, Fukui T, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2012;44:82\u201392.","journal-title":"Ann Med"},{"key":"2482_CR49","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/jdi.13306","volume":"11","author":"E Araki","year":"2020","unstructured":"Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Japanese clinical practice Guideline for Diabetes 2019. J Diabetes Investig. 2020;11:1020\u201376.","journal-title":"J Diabetes Investig"},{"key":"2482_CR50","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.clnu.2019.07.012","volume":"39","author":"OY Bello-Chavolla","year":"2020","unstructured":"Bello-Chavolla OY, Antonio-Villa NE, Vargas-V\u00e1zquez A, Viveros-Ruiz TL, Almeda-Valdes P, Gomez-Velasco D, Mehta R, Elias-L\u00f3pez D, Cruz-Bautista I, Rold\u00e1n-Valadez E, et al. Metabolic score for visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr. 2020;39:1613\u201321.","journal-title":"Clin Nutr"},{"key":"2482_CR51","doi-asserted-by":"publisher","first-page":"1411678","DOI":"10.3389\/fendo.2024.1411678","volume":"15","author":"C Torun","year":"2024","unstructured":"Torun C, Ankaral\u0131 H, Ca\u015ftur L, Uzunlulu M, Erbakan AN, Akba\u015f MM, G\u00fcnd\u00fcz N, Do\u011fan MB, Bahad\u0131r MA, O\u011fuz A. Prediction of visceral adipose tissue magnitude using a new model based on simple clinical measurements. Front Endocrinol (Lausanne). 2024;15:1411678.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2482_CR52","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2014.07.017","volume":"7","author":"RV Shah","year":"2014","unstructured":"Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, Jerosch-Herold M, Lima JA, Ding J, Allison MA. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014;7:1221\u201335.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2482_CR53","doi-asserted-by":"publisher","first-page":"102584","DOI":"10.1016\/j.dsx.2022.102584","volume":"16","author":"M Katahira","year":"2022","unstructured":"Katahira M, Moriura S, Ono S. Estimation of visceral fat area using criteria for metabolic syndrome. A cross-sectional study. Diabetes Metab Syndr. 2022;16:102584.","journal-title":"Diabetes Metab Syndr"},{"key":"2482_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4082\/kjfm.17.0099","volume":"39","author":"A Lee","year":"2018","unstructured":"Lee A, Kim YJ, Oh SW, Lee CM, Choi HC, Joh HK, Oh B, Hwang SS, Kim SJ, Kwon OD. Cut-off values for visceral Fat Area identifying Korean adults at risk for metabolic syndrome. Korean J Fam Med. 2018;39:239\u201346.","journal-title":"Korean J Fam Med"},{"key":"2482_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1259\/bjr\/38447238","volume":"85","author":"A Shuster","year":"2012","unstructured":"Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity. A critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85:1\u201310.","journal-title":"Br J Radiol"},{"key":"2482_CR56","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2337\/diacare.26.3.650","volume":"26","author":"T Hayashi","year":"2003","unstructured":"Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese americans. Diabetes Care. 2003;26:650\u20135.","journal-title":"Diabetes Care"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02482-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T07:10:29Z","timestamp":1739862629000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2482"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02482-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol received ethics approval from the Ethics Committee at Henan Provincial People\u2019s Hospital, in conformity with the Declaration of Helsinki guidelines (Approval Code: 2021 Lunar Review No. 68). The dataset was registered at clinicaltrials.gov (registration code: NCT03699228), which was part of the China Health Quantitative CT Big Data Study Group.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}